Browse > Article
http://dx.doi.org/10.3857/roj.2016.01753

The clinical utilization of radiation therapy in Korea between 2009 and 2013  

Kang, Jin-Kyu (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Kim, Mi-Sook (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Jang, Won-Il (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Seo, Young Seok (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Kim, Hee Jin (Radiation Medicine Policy Development Center, Korea Institute of Radiological & Medical Sciences)
Cho, Chul Koo (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Yoo, Hyung Jun (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Paik, Eun Kyung (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Cha, Yu Jin (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Song, Hyun Jin (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Publication Information
Radiation Oncology Journal / v.34, no.2, 2016 , pp. 88-95 More about this Journal
Abstract
Purpose: The purpose of this study was to estimate the clinical utilization of radiation therapy (RT) in Korea between 2009 and 2013. Materials and Methods: We analyzed open claims data from the Health Insurance Review and Assessment Service. The subjects were patients who had diagnostic codes C00-C97 or D00-D48 according to the 10th revision of the International Classification of Diseases, with procedure codes indicating RT treatment. Results: The total number of patients who received RT in 2009, 2010, 2011, 2012, and 2013 were 45,571, 49,593, 54,671, 59,172, and 61,485, respectively. Among them, the total numbers of male and female patients were 20,780/24,791 in 2009, 22,711/26,882 in 2010, 24,872/29,799 in 2011, 27,101/32,071 in 2012, and 27,941/33,544 in 2013. The five cancers that were most frequently treated with RT between 2009 and 2012 were breast, lung, colorectal, liver, and uterine cervical cancers. However, the fifth most common cancer treated with RT that replaced uterine cervical cancer in 2013 was prostate cancer. The three leading types of cancer among the male patients were lung, colorectal, and liver cancers, whereas in female patients, they were breast, uterine cervical, and lung cancers. The type of cancer most commonly treated by RT was cancer of the central nervous system in patients aged 20 years or less, breast cancer in patients aged 30-50 years, and lung cancer in patients aged 60 years or more. Conclusion: Data from this study provided the clinical utilization of RT in Korea between 2009 and 2013.
Keywords
Neoplasms; Radiotherapy; Statistics; Korea;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14.   DOI
2 Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 2014;46:109-23.   DOI
3 Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41.   DOI
4 Oh CM, Won YJ, Jung KW, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 2016;48:436-50.   DOI
5 Lee TJ, Kim S, Cho HJ, Lee JH. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci 2012;27:1491-8.   DOI
6 Suh M, Choi KS, Park B, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat 2016;48:1-10.   DOI
7 Yoo SY, Kim MS, Ji YH, Cho CK, Yang KM, You HJ. Statistics for Department of Radiation Oncology (1999-2001). J Korean Soc Ther Radiol Oncol 2004;22:234-6.
8 Kim MS, Ji YH, You SY, Cho CK, Yang KM, Ryu HJ. National statistics of radiation oncology in Korea (2002-2004). J Korean Soc Ther Radiol Oncol 2006;24:77-80.
9 Kim MS, Ji YH, You SY, et al. National statistics of radiation oncology in Korea (2005). J Korean Soc Ther Radiol Oncol 2006;24:207-9.
10 Ji YH, Kim MS, You SY, You DH, Choi MS, Jung HJ. National statistics of radiation oncology in Korea (2006). J Korean Soc Ther Radiol Oncol 2008;26:131-3.
11 Kang JK, Kim MS, Jang WI, et al. The clinical status of radiation therapy in Korea in 2009 and 2013. Cancer Res Treat 2015 Dec 14 [Epub]. http://dx.doi.org/10.4143/crt.2015.370.   DOI
12 Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24.   DOI
13 Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005;104:1129-37.   DOI
14 Jaen Olasolo J, Alonso Redondo E, Exposito Hernandez J, de las Penas Cabrera MD, Cabrera Roldan P. Evidence-based estimation and radiotherapy utilisation rate in Andalusia. Clin Transl Oncol 2007;9:789-96.   DOI
15 Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 2014;112:140-4.   DOI
16 Mackillop WJ, Kong W, Brundage M, et al. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in Ontario. Int J Radiat Oncol Biol Phys 2015;91:1099-107.   DOI
17 Borras JM, Lievens Y, Dunscombe P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol 2015;116:38-44.   DOI
18 Rosenblatt E, Barton M, Mackillop W, et al. Optimal radiotherapy utilisation rate in developing countries: an IAEA study. Radiother Oncol 2015;116:35-7.   DOI